RFG
MRNA icon

REAP Financial Group’s Moderna MRNA Stock Holding History

REAP Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$1.19K – 597
2024
Q2 		$1.19K Hold
10
– – ﹤0.01% 496
2024
Q1 		$1.07K Sell
10
-30
-75% -$3.02K ﹤0.01% 532
2023
Q4 		$3.98K Buy
+40
New +$3.36K ﹤0.01% 487

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

REAP Financial Group's MRNA Position: Q3 2024 in Review

REAP Financial Group sold out of Moderna (MRNA) in Q3 2024, closing a stake of 10 shares — an estimated $1.19K sold.

REAP Financial Group first reported a position in MRNA in Q4 2023 and held it in 3 quarters. The position peaked at $3.98K in Q4 2023. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • REAP Financial Group reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • REAP Financial Group sold 10 Moderna shares in Q3 2024, an estimated $1.19K.
  • REAP Financial Group first reported a position in Moderna in Q4 2023 and held it in 3 quarters.
  • REAP Financial Group's Moderna position peaked at $3.98K in Q4 2023.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on REAP Financial Group's 13F filing for Q3 2024, filed 27 Feb 2025.